Non-Stimulant Metabolic Support 5-Amino-1MQ does not rely on stimulants or appetite suppressants, making it a targeted metabolic-support option
One study utilized chitosan nanoparticles, a biocompatible and biodegradable polymer, as a carrier for doxorubicin and AOD 9604
Heres what you need to know: Target Tissue: Works specifically on adipose tissue without systemic growth hormone effects or muscle tissue impact Mechanism: Activates beta-3 adrenergic receptors on fat cell membranes, triggering intracellular fat-burning cascades Primary Action: Stimulates hormone-sensitive lipase to break down stored triglycerides into free fatty acids for energy utilization Secondary Action: Inhibits lipogenic enzymes that convert excess calories into stored fat Regional Selectivity: Particularly effective on visceral (deep abdominal) and subcutaneous fat deposits with high beta-3 receptor concentration Preservation Effect: Targets fat tissue selectively without promoting muscle protein breakdown or affecting lean tissue Unique Advantage: Does not bind to growth hormone receptors, avoiding effects on IGF-1, glucose metabolism, or insulin sensitivity Research Validation: Clinical trials with 900+ participants confirmed selective fat metabolism effects with excellent safety profile The following guide provides detailed analysis of how AOD-9604 targets fat cells, from receptor binding to metabolic outcomes
subscribe to newsletter Be the first to know about new products & special offers from Pure Health Peptides!
Quality Comparison 5-Amino-1MQ Research Overview 5-Amino-1MQ is a research compound commonly studied in relation to NNMT inhibition , metabolic signaling, cellular energy regulation, and adipocyte-related research models
It ensures the testing results are objective and reliable for research use
